ActiGraph's Response to Novel Coronavirus (COVID-19) - March 24th Update
ActiGraph Announces Launch of CentrePoint Data Hub
Pensacola, FL – June 15, 2016 – ActiGraph, a leading provider of wearable activity and sleep measurement solutions for the global pharmaceutical industry and academic research community, has announced the upcoming launch of the CentrePoint Data Hub, a home-based communication gateway that securely transmits data captured by ActiGraph activity monitors and other connected health devices to the CentrePoint cloud software platform via cellular network. The CentrePoint Data Hub is an extension of ActiGraph’s CentrePoint platform, a web-based technology suite used to deploy and manage activity monitor data collection within clinical development and health research environments.
The CentrePoint Data Hub provides a simple, flexible way for clinical trial and research study participants to share their physical activity and sleep information with the study team from the comfort of home, without the need for a PC or smartphone. The plug-and-play CentrePoint Data Hub syncs with ActiGraph activity monitors using USB 2.0 or Bluetooth LE, and collected data is seamlessly uploaded to the CentrePoint system via 3G cellular network. Participant data is immediately accessible through the CentrePoint web portal, providing the research team with an opportunity to quickly intervene if costly and time-consuming noncompliance issues arise. Real-time participant measures can also be used to inform earlier clinical decision making and support adaptive trial designs.
“The CentrePoint Data Hub was developed with two specific goals in mind,” said Jeremy Wyatt, ActiGraph CTO and Senior Vice President of Product Development. “We set out to build a solution that provides our pharma and research clients with actionable, real-time information that has the potential to impact the success of a trial. Secondly, and just as important, our solution had to be practically effortless on the part of the participants, who may already be burdened with numerous other tests and procedures.”
“We see a lot of interest from pharmaceutical clinical trial sponsors in capturing objective activity and sleep information from clinical trial patients in real time,” said James Munz, Vice President of Innovation at ERT. “This is exactly the type of solution we are exploring in our Innovation Lab – one that offers the potential for pharmaceutical companies and clinical research organizations to improve clinical trial data collection through the use of validated mHealth devices during new medical product development.”
ActiGraph’s extensively validated suite of hardware and software products are widely used by prominent scientific, academic, and pharmaceutical organizations in more than 75 countries in research studies and clinical trials involving physical activity, sedentary behavior, energy expenditure, and sleep/wake behavior. ActiGraph measurement solutions have delivered objective activity and sleep measures to many high profile population studies including the National Health and Nutrition Examination Survey (NHANES), the Harvard Women’s Health Study, the German National Cohort, and the U.K. Millennium Cohort Study.